SCHEMBL23366303

SCHEMBL23366303

CCc1c2ccccc2cn1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A3 Q92570 1/20 0.38
GABRA2 P47869 4/20 0.37
GABRB2 P47870 4/20 0.37
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
ALDH1A1 P00352 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 4/20 0.34
CYP1A2 P05177 2/20 0.34
HPGD P15428 1/20 0.34
BLM P54132 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
NR4A2 P43354 1/20 0.34
LMNA P02545 1/20 0.33
PDE4A P27815 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19068733 0.75 KDM4E (0.41) ALDH1A1L3MBTL1MAPK1POLBNPSR1
SCHEMBL11716121 0.75 GPR84 (0.38) CNR2ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL20362780 0.73 CYP2A6 (0.32) NR4A3ALDH1A1KDM4ECYP1A2HPGD
SCHEMBL11726453 0.71 GPR3 (0.46) NR4A3ALDH1A1L3MBTL1KDM4ECYP1A2
SCHEMBL20033962 0.70 KDM4E (0.34) ALDH1A1L3MBTL1POLBNPSR1KDM4E
SCHEMBL19939536 0.69 KDM4E (0.47) ALDH1A1MAPK1POLBNPSR1KDM4E
SCHEMBL6956195 0.67 HRH3 (0.42) ALDH1A1L3MBTL1POLBKDM4ECTDSP1
SCHEMBL1881313 0.67 HTR7 (0.56) NR4A2PDE4APDE4BPDE4CPDE4D
SCHEMBL21105008 0.66 KDM4E (0.56) ALDH1A1MAPK1KDM4ECYP1A2HPGD
SCHEMBL20454634 0.63 ADORA1 (0.39) ALDH1A1MAPK1POLBNPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11839144-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-12-05 US disclosed
US-11011712-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2021-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11011712-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues DPYD, DCTD, TYMP NR4A3 2133/4885GABRA2 4479/4885GABRB2 4524/4885
US-11839144-B2 Tetradentate cyclometalated platinum complexes containing 9,10-dihydroacridine and its analogues DPYD, DCTD, TYMP NR4A3 2133/4885GABRA2 4479/4885GABRB2 4524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.